SA teen pregnancy crisis: 90 000 pregnancies recorded in 2024
Teenage pregnancies 'robbing girls of their future'
Steve Letsike, Deputy Minister in the Presidency responsible for Women, Youth, and Persons with Disabilities, warns that these numbers poses a threat to South Africans.
Letsike said the scourge of teenage pregnancy is not only a health concern but a threat to the nation's social and moral fibre and future prosperity.
'Teenage pregnancy is robbing too many of our girls of their childhood and their future, and it will take all of us working together to turn the tide,' Letsike said at a stakeholder engagement in Pretoria recently aimed at addressing the persistent ongoing scourge of teenage pregnancy.
Not only a statistic but also a crime
He said 2 328 girls younger between 10 and 14-years-old recorded pregnancies last year.
'To call this alarming would be an understatement. These are children, some barely in their teens, some not even teenagers, now forced into motherhood,' Letsike said.
Letsike said a child as young as 10 becoming pregnant was not just a statistic but evidence of a profound societal failure and a horrific crime because a girl that young cannot legally give consent.
'This crisis threatens the very foundation of our social and economic development as teenage pregnancy poses a serious threat to the health, rights, education and socio-economic well-being of girls.
'When a young girl becomes a mother, her chances of finishing school plummet, her job prospects diminish, and she often becomes trapped in a cycle of poverty.
'In other words, today's teen pregnancy is tomorrow's poverty and inequality. We must recognise this as not only a public health issue but a social justice emergency,' the deputy minister said.
Letsike said the high incidence of adolescent pregnancy in the country was interlinked with other scourges of HIV and other STI infection rates, child sexual abuse, statutory rape, gender-based violence and femicide (GBVF), poverty, educational exclusion, substance abuse and even toxic elements of popular culture.
'To craft effective solutions, we must honestly confront how and why so many young girls are getting pregnant,' Letsike said.
Urgent response needed
Deputy Minister in the Presidency Nonceba Mhlauli said teenage pregnancy in South Africa has reached deeply concerning levels.
'These are not just numbers; they are a stark reflection of our socio-economic challenges and a call to action. Teenage pregnancy is more than a health crisis,' she said.
Mhlauli said the response to teenage pregnancy must be urgent, coordinated and compassionate.
'Government cannot do this work alone. We need the support of all pillars of society, parents, faith leaders, educators, civil society, the media and the private sector,' she said.
Pregnancies indicate inability to protect girls
Chairperson of the National Youth Development Agency (NYDA) Board Asanda Luwaca said 'young girls are our sisters, our classmates, our cousins, our peers and children'.
'It is an indictment of our inability, as a collective, to fully protect the bodies, rights and dreams of girls, especially those from poor, rural and marginalised communities, especially differently abled,' she said.
Luwaca said teenage pregnancy was not just about health, but injustice.
'It is about gender inequality, poverty, exploitation, broken family systems, absent accountability and a dangerous silence that protects perpetrators more than it protects girls.
'And until we confront these intersecting issues head-on with honesty, bravery and unflinching determination, we will continue to fail the young women of this nation. South Africa has the policies. We have the frameworks. What we need now is unapologetic implementation across every level of society,' Luwaca said.
The engagement with stakeholders is part of an initiative to establish a Roadmap to South Africa's Teenage Pregnancy Prevention and Management Response. – SAnews.gov.za
Breaking news at your fingertips… Follow Caxton Network News on Facebook and join our WhatsApp channel.
Nuus wat saakmaak. Volg Caxton Netwerk-nuus op Facebook en sluit aan by ons WhatsApp-kanaal.
Read original story on www.citizen.co.za
At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Citizen
an hour ago
- The Citizen
Zishan finds life-saving stem cell donor
When nine-year-old Zishan Reddy was diagnosed with leukaemia for the second time and needed a bone marrow transplant, his mother Goolshun, family friends, and the Ashton International College community sprang into action in the hopes of finding a donor. Goolshun issued a heartfelt plea for potential donors to register with the South African Bone Marrow Registry (SABMR), while Ashton hosted a stem cell donor drive on May 30. In a show of solidarity, teacher Robyn Daniel also dedicated her June 8 Comrades Marathon run to Zishan's fight. While Goolshun says she is 'eternally grateful for the support from South Africans', she never imagined that her son's match would come from nearly 7 300km away, in India. 'When Dr Kate Bennett shared the news with Zishan, he just threw his hands up in the air and said, 'Yes, yes, yes!' I could just see the excitement in his face,' said Goolshun. 'But with all the excitement also comes some anxiety. We are just taking it day by day,' she added. ALSO READ: Robyn achieves Comrades PB for little leukemia sufferer 'All we know is that the donor is from India, and we are eternally grateful to them for giving so selflessly and being willing to save another life. We are relieved it's a great match for my little warrior, Zishan. 'We continue to pray the transplant will be an easy and painless journey for him. We trust his strength, courage and fighting spirit will carry him through.' She extended heartfelt thanks to everyone who supported them during this journey: 'We are eternally grateful for all the love and support and hope you will continue to help others still waiting for a transplant. Thank you, and God bless, from my family to yours.' She had special words for her daughter: 'To my daughter Thuraya, thank you for being the best big sister. You are such a strong, beautiful girl, and I am super proud of you. We love you very much.' She also praised Robyn Daniel for her dedication and continued support: 'A very special thank you to Robyn for her love and support of our family. It is so heart-warming and means so much to us. She has continued to keep in touch with Zishan's treatment through regular messages. She has a heart full of love and care.' Zishan recently spent five days at Netcare Unitas Hospital receiving radiation and has since been transferred to the Wits University Donald Gordon Medical Centre, where the next phase of his transplant will begin. ALSO READ: It would mean the world to Zishan if he gets a stem cell donor
TimesLIVE
3 hours ago
- TimesLIVE
Findings give hope for monthly HIV prevention pill
There are several antiretroviral formulations proven to prevent HIV infection: a daily pill, two different jabs that offer protection for two and six months respectively, and a vaginal ring for women that has to be replaced monthly. In a few years, a long-acting pill may join the ranks, if it works. The pill, for now called MK-8527, has the potential to prevent HIV infection for up to a month in its current formulation. It is a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which means it disrupts a specific step in the cycle by which the virus makes copies of itself. The pill is now moving onto pivotal phase-three trials, after promising results from a smaller phase-two study presented at the International Aids Society (IAS) conference held in Kigali, Rwanda. The phase-two study, conducted in trial sites in South Africa, the US and Israel showed that MK-8527 was well tolerated and had a safety profile similar to a placebo. It also showed the levels of the antiretroviral were at the required levels in the bodies of study participants, though the study was not designed to determine whether it is effective. Whether MK-8527 actually prevents HIV infection will now be tested in two large phase-three studies across multiple countries, including South Africa. In these studies, the efficacy of the monthly pill will be compared with a daily HIV prevention pill that is already widely available in South Africa's public sector. The daily pill contains the antiretroviral drugs tenofovir disaproxil fumarate and emtricitabine. Latest findings The phase-two study looked at three different doses of the monthly pill — 3mg, 6mg and 12mg — as well as a placebo. The 350 participants, about one third of which were from South Africa, were given one pill (either an active pill or placebo) every month for six months. They were monitored for at least two months afterwards. None of the participants acquired HIV during the study. The researchers enrolled adults who were at a low risk of being exposed to HIV and excluded pregnant and breastfeeding women, and people who had previously used MK-8527 or a similar antiretroviral drug called Islatravir, said Dr Kenneth Mayer, a professor of medicine at Harvard Medical School, who presented the findings in Kigali earlier this month. The levels of the antiretroviral in the blood of all the participants were measured on day one and two, on the last day of taking the pill, and again at the first follow-up visit after stopping the pill. Based on these results, Mayer said there doesn't appear to be a build-up of drugs in the body that might prove toxic over time. This supports evaluating the use of a monthly pill over a longer period (than the six months in the study), he said, 'without concern that increasing drug levels will cause toxicity after a longer period of monthly administration'.
Daily Maverick
11 hours ago
- Daily Maverick
More than 70 million people in Africa are living with chronic viral hepatitis
Two to three million South Africans have chronic viral hepatitis, with most remaining undiagnosed and untreated. Hepatitis occurs when different viruses cause inflammation of the liver. Hepatitis A (HAV) and hepatitis E (HEV) viruses are mainly spread through contaminated food or water and typically cause self-limiting infections. This means that following a short period of illness — ranging from mild to severe and occasionally life-threatening — the affected person usually recovers fully. In contrast, three other types of hepatitis viruses — hepatitis B (HBV), C (HCV) and D (HDV) — are transmitted mainly through contact with infected bodily fluids such as blood, saliva and semen. This may lead to chronic infection of the liver, meaning the infection persists for at least six months. Chronic infection may last for life, and carriers, as people with chronic infection are called, remain infectious and can pass the infection to their close contacts without ever knowing they are infected. The younger someone is when becoming infected, the higher the risk of developing a chronic infection. Mother-to-child transmission A mother can also pass HBV to her child during childbirth, especially when she has a high concentration of the virus in her blood. More than 90% of babies infected by their mothers will become carriers. Mother-to-child transmission of HBV is a major contributor to the global burden of chronic HBV infection. Fortunately, HBV infection can be prevented with a safe and effective vaccine. While there is no vaccine for HCV, it can be treated and cured using effective antiviral medications. Chronic HBV and HCV infections, unless recognised and treated on time, may eventually lead to serious, often fatal conditions such as liver cirrhosis or primary liver cancer. Of the more than 300 million people worldwide estimated to be living with chronic HBV or HCV infection, more than 70 million are in Africa. Two to three million South Africans have chronic viral hepatitis, with most remaining undiagnosed and untreated. Studies from our group and others have shown that chronic HBV infection is responsible for more than 60% of primary liver cancer cases in South Africa. Primary liver cancer is more common in males and tends to develop relatively early in adulthood, cutting lives short. Alarmingly, chronic infection often goes unnoticed until it causes serious complications, by which time treatment options are very limited and usually too late. Public awareness It is therefore fitting that 28 July is commemorated annually as World Hepatitis Day to raise public awareness of viral hepatitis. The theme for 2025, Hepatitis: Let's Break It Down, is aimed at dismantling various obstacles — including financial, social and systemic barriers — that stand in the way of eliminating viral hepatitis as a public health threat by 2030. South Africa has been making commendable progress towards eliminating viral hepatitis as a public health threat. The country introduced the vaccine against HBV in the Expanded Programme on Immunisation in 1995. This has led to a significant decline in the number of infections among children under the age of five. Nevertheless, some children continue to be infected because their mothers are not tested for HBV. This can be done using a simple rapid test, and if pregnant women are found to be infected with HBV, antiviral therapy will reduce the risk of transmitting the virus to their children. Pregnant women Diagnosing pregnant women with chronic hepatitis is an entry point to medical care — not only for their own health, but also that of their sexual partners and other family members who should also be screened for HBV. In 2024, South Africa started screening pregnant women for HBV and rolling out a birth dose HBV vaccine for babies born to infected mothers. This is a long-overdue move. It is still too early to evaluate its success, which depends on full commitment from all relevant stakeholders in all provinces. A simpler alternative that is less prone to implementation issues would be to administer the birth dose HBV vaccine to every baby instead of waiting until they are six weeks old, regardless of the mother's status. While eliminating new HBV infections among children is crucial, it is equally important to diagnose those who are already infected. Diagnosis is the gateway to care. This includes antiviral treatment and regular monitoring to enable early detection of liver cancer should it develop. The latest World Health Organization guidelines for management of chronic HBV infection have been simplified by abandoning previously complicated algorithms that excluded many people who could benefit from antiviral therapy. It is estimated that currently, fewer than 10% of those who should be getting treatment for chronic viral hepatitis are receiving it. Economic benefit Diagnosing and treating more chronically infected individuals requires financial resources. It is highly likely to be cost-effective from an economic standpoint, as severe illness and death affect adults in their productive years. In addition, it will kill two birds with one stone: to prevent serious illness in the infected person and to prevent new infections. The same applies to HIV: someone who is on treatment and has a low or undetectable viral load is essentially no longer infectious to others. However, there is an urgent need to identify funding mechanisms, particularly considering the current US administration's withdrawal of donor aid. It will be wise for African countries to come together and speak with one voice when entering into any negotiations with pharmaceutical companies that manufacture antivirals for chronic viral hepatitis. Societal barriers and misinformation While providing the necessary preventative and treatment methods, we also must break down societal barriers that hinder access to clinical care. We must also address misinformation. We have heard sad stories from individuals with chronic viral hepatitis during our community engagement initiatives of being ostracised within the community because of miseducation on how the infection is transmitted and its complications. Some patients with viral hepatitis have been accused of promiscuity, while in certain cases, the development of liver cancer has been blamed on witchcraft. Health educators will need to do more to educate the general public. It will also be beneficial to have functional support groups of people living with viral hepatitis, while the involvement of prominent individuals can also help to raise awareness about viral hepatitis. We can learn from public health responses to other viral infections and borrow some of the strategies to address viral hepatitis. Together we can 'break it down.' DM
